Analysis of AHG-PRA and ELISA-PRA in kidney transplant patients with acute rejection episodes

Transplant Immunology

Volumn 11, Issue 2, 2003, Pages 175-178

  Kaufman, Arnauld ^a   Faria de Souza Pontes, Luciane ^a   Queiroz Marques, Maria Teresa ^a   Sampaio, José Cavaliere ^a   Cristóvão de Moraes Sobrino Porto, Luís ^a   Régio de Moraes Souza, Edison ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Acute rejection; AHG; Anti HLA antibodies; ELISA; HLA; Kidney transplantation

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN; HLA ANTIBODY; LYMPHOCYTE ANTIBODY; OKT 3; OKT3 ORTHOCLONE; PREDNISONE;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; ANTIBODY DEPENDENT LYMPHOCYTOTOXICITY; ANTIBODY PRODUCTION; ARTICLE; BIOPSY; BLOOD ANALYSIS; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION COEFFICIENT; CORRELATION FUNCTION; CREATININE BLOOD LEVEL; EDEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; KIDNEY ALLOGRAFT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; OLIGURIA; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RECIPIENT; RISK ASSESSMENT; WEIGHT GAIN;

ADOLESCENT; ADULT; ANTIBODIES; CHILD; CYTOTOXICITY TESTS, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0038037893     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(03)00003-0     Document Type: Article

References (20)

1. Gulanikar AC, Mac Donald AS, Sungurtekin U, Belitsky P. The incidence and impact of early rejection episodes on graft outcome in recipients of first cadaver kidney transplants. Transplantation 1992;53(2):323-328.
2. Monteiro F, Mineiro C, Rodrigues H, De Paula FJ, Kalil J. Pretransplant and posttransplant monitoring of anti-HLA class I IgG1 antibodies by ELISA identifies patients at high risk of graft loss. Transplant Proc 1997;29:1433-1434.
3. Feucht HE, Opelz G. The humoral immune response towards HLA class II determinants in renal transplantation (editorial). Kidney Int 1996;50(5):1464-1475.
4. Halloran PF, Wadgymar A, Ritchie S, Falk J, Solez K, Srinivasa NS. The significance of the anti-class I antibody response. 1. Clinical and pathological features of anti-class I mediated rejection. Transplantation 1990;49:85-91.
5. Nanni-Costa A, Scolari MP, Ianneli S, et al. The presence of posttransplant HLA-specific antibodies detected by ELISA correlates with specific rejection pathologies. Transplantation 1997;63:167-169.
6. Kerman RH, Susskind B, Kerman DH, et al. Anti-HLA antibodies detected in posttransplant renal allograft recipient sera correlate with chronic rejection. Transplant Proc 1997;29:1515-1516.
7. Vaidya S. T and B lymphocyte crossmatches using immunomagnetic beads. In: Nikaein A, editor. 3rd ed. ASHI Laboratory Manual. Lenexa, KS: American Society of Histocompatibility and Immunogenetics, 1995. p. I.C.2.1-I.C.2.7.
8. Noreen HL. Interpretation of crossmatch tests. In: Nikaein A, editor. 3rd ed. ASHI Laboratory Manual. Lenexa, KS: American Society of Histocompatibility and Immunogenetics, 1995. p. I.C.1.1-I.C.1.13.
9. Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology. Kidney Int 1993;44:411-422.
10. Hopkins KA. Basic microlymphocytotoxicity test. In: Nikaein A, editor. 3rd ed. ASHI Laboratory Manual. Lenexa, KS: American Society of Histocompatibility and Immunogenetics, 1995. p. I.B.1.1-I.B.1.13.
11. Zmijewski C. Overview of detection and identification of HLA antibodies. In: Nikaein A, editor. 3rd ed. ASHI Laboratory Manual. Lenexa, KS: American Society of Histocompatibility and Immunogenetics, 1995. p. I.D.1.1-I.D.1.14.
12. Wang G, Tarsitani C, Takemura S, Pei R, Liu AN, Lee JH. ELISA assay for the detection of specific antibodies to class I HLA antigens in transplant patients with panel reactive antibodies. Proceedings of the Second Annual ASHI Meeting. Human Immunol; 1996;49(1):109.
13. Kerman RH, Susskind B, Buelow R, et al. Correlation of ELISA-detected IgG and IgA anti-HLA antibodies in pretransplant sera with renal allograft rejection. Transplantation 1996;62(2):201-205.
14. McKenna RM, Takemoto SK, Terasaki PI. Anti-HLA antibodies after solid organ transplantation. Transplantation 2000;69(3):319-326.
15. Kerman RH, Van Buren CT, Lewis RM, Kahan BD. Impact of blood transfusions and HLA on cyclosporine-treated renal transplant recipients. Transplant Proc 1988;20(Suppl 3):264-269.
16. Kao K-J, Scornik JC, Small SJ. Enzyme linked immunoassay for anti-HLA antibodies - An alternative to panel studies by lymphocytotoxicity. Transplantation 1993;55:192-196.
17. Buelow R, Chiang TR, Monteiro F, et al. Soluble HLA antigens and ELISA: A new technology for crossmatch testing. Transplantation 1995;60(12):1594-1599.
18. Kerman RH, Susskind B, Kerman D, et al. Comparison of PRA-STAT, sHLA-EIA and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: Correlation to rejection and posttransplant coronary artery disease. J Heart Lung Transplant 1998;17(8):789-794.
19. Christiaans MHL, Nieman F, Van Hooff JP, Van Den Berg-Loonen EM. Detection of HLA class I and II antibodies by ELISA and complement-dependent cytotoxicity before and after transplantation. Transplantation 2000;69(5):917-927.
20. Monteiro F, Buelow R, Mineiro C, Rodrigues H, Kalil J. Identification of patients at high risk of graft loss by pre- and posttransplant monitoring of anti-HLA class I IgG antibodies by enzyme-linked immunosorbent assay. Transplantation 1997;63(4):542-546.